Sino-Agri Leading BiosciencesLtd Future Growth
Future criteria checks 3/6
Sino-Agri Leading BiosciencesLtd is forecast to grow earnings and revenue by 23.8% and 14.9% per annum respectively. EPS is expected to grow by 23.9% per annum. Return on equity is forecast to be 18% in 3 years.
Key information
23.8%
Earnings growth rate
23.9%
EPS growth rate
Chemicals earnings growth | 39.7% |
Revenue growth rate | 14.9% |
Future return on equity | 18.0% |
Analyst coverage | Low |
Last updated | 06 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Sino-Agri Leading BiosciencesLtd (SHSE:603970) Seems To Use Debt Quite Sensibly
Sep 27Benign Growth For Sino-Agri Leading Biosciences Co.,Ltd (SHSE:603970) Underpins Stock's 25% Plummet
Jul 15Sino-Agri Leading BiosciencesLtd's (SHSE:603970) Shareholders May Want To Dig Deeper Than Statutory Profit
May 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 14,891 | 379 | N/A | -224 | 2 |
12/31/2025 | 12,863 | 303 | N/A | 1,125 | 2 |
12/31/2024 | 11,297 | 248 | N/A | 194 | 2 |
9/30/2024 | 10,610 | 218 | 117 | 121 | N/A |
6/30/2024 | 10,706 | 231 | -630 | -625 | N/A |
3/31/2024 | 10,514 | 228 | -877 | -872 | N/A |
12/31/2023 | 10,460 | 225 | -949 | -944 | N/A |
9/30/2023 | 10,380 | 223 | -475 | -472 | N/A |
6/30/2023 | 11,890 | 224 | 682 | 687 | N/A |
3/31/2023 | 12,007 | 219 | 1,129 | 1,132 | N/A |
12/31/2022 | 11,699 | 210 | 1,532 | 1,536 | N/A |
9/30/2022 | 11,032 | 202 | 1,857 | 1,861 | N/A |
6/30/2022 | 10,039 | 198 | 708 | 707 | N/A |
3/31/2022 | 9,036 | 180 | 195 | 198 | N/A |
12/31/2021 | 8,822 | 170 | 321 | 325 | N/A |
9/30/2021 | 8,933 | 162 | -156 | -142 | N/A |
6/30/2021 | 7,978 | 152 | 155 | 176 | N/A |
3/31/2021 | 7,102 | 138 | 285 | 300 | N/A |
12/31/2020 | 6,641 | 132 | 337 | 352 | N/A |
9/30/2020 | 6,119 | 130 | 227 | 230 | N/A |
6/30/2020 | 5,260 | 125 | 316 | 318 | N/A |
3/31/2020 | 4,521 | 120 | 122 | 125 | N/A |
12/31/2019 | 4,342 | 119 | 216 | 219 | N/A |
9/30/2019 | 4,195 | 121 | -185 | -183 | N/A |
6/30/2019 | 4,015 | 121 | 35 | 37 | N/A |
3/31/2019 | 3,850 | 120 | 126 | 124 | N/A |
12/31/2018 | 3,735 | 115 | 57 | 66 | N/A |
9/30/2018 | 3,561 | 109 | 2 | -17 | N/A |
6/30/2018 | 3,573 | 106 | N/A | 28 | N/A |
3/31/2018 | 3,629 | 96 | N/A | 236 | N/A |
12/31/2017 | 3,503 | 90 | N/A | 519 | N/A |
9/30/2017 | 3,489 | 88 | N/A | 579 | N/A |
12/31/2016 | 3,398 | 82 | N/A | 152 | N/A |
12/31/2015 | 3,234 | 88 | N/A | -254 | N/A |
12/31/2014 | 2,875 | 81 | N/A | 40 | N/A |
12/31/2013 | 2,488 | 69 | N/A | -80 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603970's forecast earnings growth (23.8% per year) is above the savings rate (2.8%).
Earnings vs Market: 603970's earnings (23.8% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 603970's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 603970's revenue (14.9% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 603970's revenue (14.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603970's Return on Equity is forecast to be low in 3 years time (18%).